Literature DB >> 1903428

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.

B Van den Eynde1, B Lethé, A Van Pel, E De Plaen, T Boon.   

Abstract

We showed previously that mouse mastocytoma P815 expresses several distinct antigens that are recognized by cytolytic T lymphocytes (CTL) of syngeneic DBA/2 mice. Antigens P815A and P815B are usually lost jointly and are targets for immune rejection responses in vivo. We used a cosmid library and a CTL stimulation assay to obtain transfectants expressing tumor rejection antigen P815A. From these transfectants we retrieved gene P1A which transferred the expression of both P815A and B. This gene is unrelated to three previously isolated genes coding for tum-antigens. It encodes a putative protein of 224 amino acids which contains two highly acidic domains showing homology with similar regions of nuclear proteins. The P1A gene expressed by tumor P815 is completely identical to the gene present in normal DBA/2 cells. Expression of the gene was tested by Northern blots. Cells from liver, spleen, and a number of mast cell lines were negative, but mast cell line L138.8A produced a high level of P1A message and was lysed by CTL directed against antigens P815A and B. We conclude that major tumor rejection antigens of P815 are encoded by a gene showing little or no expression in most normal cells of adult mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903428      PMCID: PMC2190831          DOI: 10.1084/jem.173.6.1373

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.

Authors:  T Wölfel; A Van Pel; E De Plaen; C Lurquin; J L Maryanski; T Boon
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Rapid and sensitive protein similarity searches.

Authors:  D J Lipman; W R Pearson
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

4.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 5.  Protein import into the cell nucleus.

Authors:  C Dingwall; R A Laskey
Journal:  Annu Rev Cell Biol       Date:  1986

6.  Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture.

Authors:  H U Bernard; G Krämmer; W G Röwekamp
Journal:  Exp Cell Res       Date:  1985-05       Impact factor: 3.905

7.  Structure of the mouse nucleolin gene. The complete sequence reveals that each RNA binding domain is encoded by two independent exons.

Authors:  H M Bourbon; B Lapeyre; F Amalric
Journal:  J Mol Biol       Date:  1988-04-20       Impact factor: 5.469

8.  Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene.

Authors:  E R Fearon; T Itaya; B Hunt; B Vogelstein; P Frost
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

9.  Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.

Authors:  E De Plaen; C Lurquin; A Van Pel; B Mariamé; J P Szikora; T Wölfel; C Sibille; P Chomez; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Mouse histocompatibility genes: structure and organisation of a Kd gene.

Authors:  S Kvist; L Roberts; B Dobberstein
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  74 in total

1.  The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.

Authors:  T Matsutake; P K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC).

Authors:  K J Palmer; M Harries; M E Gore; M K Collins
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

3.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

4.  Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.

Authors:  Luc Pilotte; Pierre Larrieu; Vincent Stroobant; Didier Colau; Eduard Dolusic; Raphaël Frédérick; Etienne De Plaen; Catherine Uyttenhove; Johan Wouters; Bernard Masereel; Benoît J Van den Eynde
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

5.  The discovery of cancer/testis antigens by autologous typing with T cell clones and the evolution of cancer vaccines.

Authors:  Elke Jäger; Alexander Knuth
Journal:  Cancer Immun       Date:  2012-05-01

Review 6.  Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens.

Authors:  P Romero
Journal:  Springer Semin Immunopathol       Date:  1996

7.  5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.

Authors:  Malgorzata Wachowska; Magdalena Gabrysiak; Angelika Muchowicz; Weronika Bednarek; Joanna Barankiewicz; Tomasz Rygiel; Louis Boon; Pawel Mroz; Michael R Hamblin; Jakub Golab
Journal:  Eur J Cancer       Date:  2014-02-18       Impact factor: 9.162

8.  Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity.

Authors:  Anil Shanker; Michel Buferne; Anne-Marie Schmitt-Verhulst
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

9.  Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.

Authors:  María García-Díaz; Masayoshi Kawakubo; Pawel Mroz; M Lluïsa Sagristà; Margarita Mora; Santi Nonell; Michael R Hamblin
Journal:  J Control Release       Date:  2012-07-27       Impact factor: 9.776

10.  Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.

Authors:  E Shiloni; S E Karp; M C Custer; J Shilyansky; N P Restifo; S A Rosenberg; J J Mulé
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.